Comparison of benefits, harms, and resource requirements across screening
programs to help countries prioritise screening interventions

Summary

Estimates of effectiveness and costs of screening interventions from tasks 10.2 and 10.3 will be integrated in a predictive model to derive comparative estimates of the impact of different screening (and possibly primary prevention) interventions, using DALYs as a common metric to account for the health impact of the interventions. Using the information about the economic value of a DALY and about the cost of the considered interventions, the
model will allow to estimate the timing of the ROI. Results of these analyses will be used to inform the prioritisation process adopting the methodology developed in task 4.4, to support policy decision about which intervention to prioritise by country/region. We will test the model in exemplary countries from task 4.4 and in non-exemplary countries, to share experiences and discuss similarities and differences.
This task will be led by CPO, Italy, co-led by EMC, Netherlands.

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen VerticalThe general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο